Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mild-to-moderate Essential Hypertension”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00856271
What this trial is testing

Olmesartan Medoxomil Versus Losartan Potassium in Patients With Mild to Moderate Essential Hypertension

Who this might be right for
Essential Hypertension
Daiichi Sankyo 287
Testing effectiveness (Phase 2)Study completedNCT00701649
What this trial is testing

Study to Evaluate Safety and Tolerability, Pharmacodynamic Effects and Exploratory Efficacy of a Vaccine Against Essential Hypertension

Who this might be right for
Hypertension
Cytos Biotechnology AG 60
Post-approval studies (Phase 4)Study completedNCT00328965
What this trial is testing

Lacidipine In Mild To Moderate Essential Hypertension Patients With Type 2 Diabetes In Korea

Who this might be right for
Diabetes Mellitus, Type 2Essential Hypertension
GlaxoSmithKline
Testing effectiveness (Phase 2)Study completedNCT00710372
What this trial is testing

Safety, Tolerability and Efficacy of a Vaccine Against Essential Hypertension

Who this might be right for
Mild Essential HypertensionModerate Essential Hypertension
Cytos Biotechnology AG 83
Testing effectiveness (Phase 2)Study completedNCT01289132
What this trial is testing

Efficacy and Safety of Azilsartan in Participants With Mild to Moderate Uncomplicated Essential Hypertension

Who this might be right for
Essential Hypertension
Takeda 926
Large-scale testing (Phase 3)Study completedNCT00139698
What this trial is testing

Olmesartan Alone or in Combination With Hydrochlorothiazide in Subjects With Mild to Moderate Essential Hypertension

Who this might be right for
Essential Hypertension
Pfizer 410
Large-scale testing (Phase 3)Study completedNCT00857285
What this trial is testing

Olmesartan Medoxomil Versus Losartan in Patients With Hypertension

Who this might be right for
Essential Hypertension
Daiichi Sankyo 130
Post-approval studies (Phase 4)UnknownNCT06501651
What this trial is testing

Sacubitril/Valsartan Treats Patients With Essential Hypertension and Type 2 Diabetic Nephropathy

Who this might be right for
Essential HypertensionType 2 DiabetesNephropathy
Sichuan Academy of Medical Sciences 297
Early research (Phase 1)Study completedNCT00424541
What this trial is testing

Pharmacokinetic and Pharmacodynamic Profiles of Aliskiren in Japanese Patients With Mild to Moderate Essential Hypertension

Who this might be right for
Hypertension
Novartis 34
Large-scale testing (Phase 3)Study completedNCT00413049
What this trial is testing

Efficacy/Safety of Valsartan Plus Amlodipine and Amlodipine Alone in Patients With Hypertension

Who this might be right for
Hypertension
Novartis 698
Large-scale testing (Phase 3)Study completedNCT00367094
What this trial is testing

Combination of Benazepril Plus Hydrochlorothiazide in Chinese Patients With Mild to Moderate Essential Hypertension

Who this might be right for
Hypertension
Novartis 296
Large-scale testing (Phase 3)Study completedNCT01135212
What this trial is testing

The Clinical Study to Evaluate the Efficacy and Safety of Fimasartan in Patients With Mild to Moderate Essential Hypertension

Who this might be right for
Hypertension
Boryung Pharmaceutical Co., Ltd 290
Testing effectiveness (Phase 2)Study completedNCT03756103
What this trial is testing

Safety and Efficacy of SPH3127 on Treating Mild-moderate Essential Hypertension Patients

Who this might be right for
Hypertension,Essential
Shanghai Pharmaceuticals Holding Co., Ltd 120
Testing effectiveness (Phase 2)Study completedNCT02222480
What this trial is testing

A Clinical Trial to Evaluate Efficacy, Tolerability, and Pharmacokinetic-Pharmacodynamic Relationship of Fimasartan/Hydrochlorothiazide

Who this might be right for
Hypertension
Boryung Pharmaceutical Co., Ltd 103
Large-scale testing (Phase 3)Study completedNCT01001572
What this trial is testing

Efficacy and Safety of Valsartan/Amlodipine in Patients With Mild to Moderate Essential Hypertension

Who this might be right for
Essential Hypertension
Novartis 932
Testing effectiveness (Phase 2)Ended earlyNCT01373086
What this trial is testing

LFF269 Compared to Placebo After Treatment in Subjects With Essential Hypertension

Who this might be right for
Hypertension
Novartis Pharmaceuticals 19
Post-approval studies (Phase 4)Study completedNCT01431508
What this trial is testing

Safety and Efficacy in MK-0954A Combination in Participants With Hypertension (MK-0954A-373 AM3)

Who this might be right for
Hypertension
Organon and Co 15
Large-scale testing (Phase 3)Study completedNCT00257491
What this trial is testing

Study to Evaluate the Trough and Peak Effect of Once Daily Telmisartan 80 mg/Hydrochlorothiazide 12.5 mg (Micardis Plus) by Ambulatory Blood Pressure Monitoring (ABPM) in Patients With Mild to Moderate Essential Hypertension

Who this might be right for
Hypertension
Boehringer Ingelheim 29
Large-scale testing (Phase 3)UnknownNCT01956786
What this trial is testing

Efficacy of Amlodipine-Folic Acid Tablets on Reduction of Blood Pressure and Plasma Homocysteine

Who this might be right for
Essential Hypertension
Shenzhen Ausa Pharmed Co.,Ltd 540
Testing effectiveness (Phase 2)Study completedNCT00950066
What this trial is testing

Irbesartan and Amlodipine Combination in Controlling Blood Pressure

Who this might be right for
Hypertension
Sanofi 270
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation